Review




Structured Review

Jackson Laboratory faps
Faps, supplied by Jackson Laboratory, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/faps/faps/pm38723870-173-0-10
Average 86 stars, based on 1 article reviews
faps - by Bioz Stars, 2026-11
86/100 stars

Images

Related Articles

Cell Culture:

Article Title: LPA-induced expression of CCN2 in muscular fibro/adipogenic progenitors (FAPs): Unraveling cellular communication networks.
Article Snippet: Cellular Communication Network Factor 2, CCN2, is a profibrotic cytokine implicated in physiological and pathological processes in mammals.. The expression of CCN2 is markedly increased in dystrophic muscles.. Interestingly, diminishing CCN2 genetically or inhibiting its function improves the phenotypes of chronic muscular fibrosis in rodent models.



Similar Products

94
MedChemExpress anti fap antibodies
Anti Fap Antibodies, supplied by MedChemExpress, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/faps/Anti-Mouse+FAP+Antibody/pmc13650241-281-16-21
Average 94 stars, based on 1 article reviews
anti fap antibodies - by Bioz Stars, 2026-11
94/100 stars
  Buy from Supplier

93
NSJ Bioreagents fibroblast activation protein alpha antibody / fap
Fibroblast Activation Protein Alpha Antibody / Fap, supplied by NSJ Bioreagents, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/faps/Fibroblast+Activation+Protein+Alpha+Antibody+%2F+FAP/custom%40v9470%4042930035
Average 93 stars, based on 1 article reviews
fibroblast activation protein alpha antibody / fap - by Bioz Stars, 2026-11
93/100 stars
  Buy from Supplier

94
RayBiotech inc human fap sandwich elisa kit
( A ) Histopathology and protein content analysis was performed on tissue from mNAA, fNAA, mAAA and fAAA using immunofluorescence (IF), Western blot and <t>ELISA.</t> Panel A was made using BioRender.com. ( B ) IF staining of human abdominal aortic tissue for all groups with α-SMA (Green), <t>FAP</t> (Red) and DAPI (Blue). Co-localized cells (Yellow) represent VSMCs that express FAP marker. ( C ) IF quantification of VSMC counts using α-SMA antibody across all groups. ( D ) IF quantification of FAP+ cells using FAP antibody across all groups. ( E ) Tissue FAP concentration measured by ELISA. ( F ) Ratio of FAP+ cells that are not VSMCs. AU = Arbitrary Units. Data presented as mean ± SD. Ns>0.005, *p<0.05, **p<0.01, ***p<0.001 using Mann-Whitney-test.
Human Fap Sandwich Elisa Kit, supplied by RayBiotech inc, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/faps/Human+FAP+ELISA/bio_rxiv__64898__2026__10__23__761467-56-17-22
Average 94 stars, based on 1 article reviews
human fap sandwich elisa kit - by Bioz Stars, 2026-11
94/100 stars
  Buy from Supplier

93
R&D Systems fibroblast activation protein
( A ) Histopathology and protein content analysis was performed on tissue from mNAA, fNAA, mAAA and fAAA using immunofluorescence (IF), Western blot and <t>ELISA.</t> Panel A was made using BioRender.com. ( B ) IF staining of human abdominal aortic tissue for all groups with α-SMA (Green), <t>FAP</t> (Red) and DAPI (Blue). Co-localized cells (Yellow) represent VSMCs that express FAP marker. ( C ) IF quantification of VSMC counts using α-SMA antibody across all groups. ( D ) IF quantification of FAP+ cells using FAP antibody across all groups. ( E ) Tissue FAP concentration measured by ELISA. ( F ) Ratio of FAP+ cells that are not VSMCs. AU = Arbitrary Units. Data presented as mean ± SD. Ns>0.005, *p<0.05, **p<0.01, ***p<0.001 using Mann-Whitney-test.
Fibroblast Activation Protein, supplied by R&D Systems, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/faps/Mouse+Fibroblast+Activation+Protein+alpha%2FFAP+Antibody/10__3390_slash_organoids5040033-110-29-33
Average 93 stars, based on 1 article reviews
fibroblast activation protein - by Bioz Stars, 2026-11
93/100 stars
  Buy from Supplier

96
ABclonal Biotechnology fap
miR-1290 is upregulated in breast cancer and BCAF/MB-231-derived exosomes. a Nanoparticle tracking analysis of exosomes isolated from BCAFs and MB-231 cells showing their size distribution. The mean size and standard deviation (SD) are indicated for each sample. b TEM images of exosomes isolated from BCAFs (upper) and MB-231 cells (lower) showing the characteristic morphology of the exosomes. Scale bar, 100 nm. c Western blot analysis of exosome markers <t>(CD63,</t> <t>CD81,</t> and flotillin-1), CAF markers (α-SMA and <t>FAP)</t> and cellular markers (GM130 and H3) in BCAF cells, MB-231 cells and their derived exosomes. d BCAF-derived exosome uptake by TNBC cells. PKH67-labeled BCAF-derived exosomes (green) were incubated with BT-549 and Hs578T cells for 1 hour. The cell nuclei were stained with Hoechst 33342 (blue). Scale bar, 20 μm. e Heatmap showing miRNA expression profiles in exosomes derived from BCAFs and MB-231 cells. Red indicates high expression, and blue indicates low expression. miR-1290 (highlighted in red) is highly expressed in both exosome types. f Volcano plots showing differentially expressed miRNAs between breast cancer or TNBC samples and normal controls in five independent GEO datasets ( GSE37963 , GSE45666 , GSE45498 , GSE38167 , and GSE61438 ). Red and blue dots represent upregulated and downregulated miRNAs, respectively, selected using fold-change and nominal p value cutoffs (|log2(fold change)| > 0.58 and nominal p < 0.05, two-tailed Welch’s t test). g Venn diagram analysis of upregulated miRNAs across the five GEO datasets revealed four commonly upregulated miRNAs. h Violin plot showing miR-1290 expression levels in serum samples from normal individuals ( N , n = 2686) and breast cancer patients ( P , n = 1280) from the GSE73002 dataset. The expression of miR-1290 was significantly upregulated in the breast cancer patient samples (*** p < 0.001, Mann‒Whitney U test). i Analysis of serum exosomal miR-1290 levels in normal ( N , n = 20) and TNBC patient ( P , n = 39) samples collected at Keimyung University Dongsan Hospital. The results support the potential of miR-1290 as a candidate diagnostic marker in an independent cohort (*** p < 0.001, Mann‒Whitney U test). j Kaplan‒Meier plot of overall survival for TNBC patients based on serum exosomal miR-1290 expression levels from Keimyung University Dongsan Hospital ( p = 0.006, log-rank test)
Fap, supplied by ABclonal Biotechnology, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/faps/alpha+smooth+muscle+Actin+Rabbit+mAb/pmc13612446-411-24-26
Average 96 stars, based on 1 article reviews
fap - by Bioz Stars, 2026-11
96/100 stars
  Buy from Supplier

94
TargetMol fap α inhibitor sp 13786
FAP α + HSCs upregulate NF- κ B/NLRP3/caspase-1/IL-18 signaling pathway. (A) KEGG analysis of the Top100 upregulated genes in LX-2 FAP cells. (B) GO analysis of paracancerous and healthy HSCs from scRNA sequencing. (C) Western blotting analysis of FAP α , NF κ B-p65, p- NF κ B-p65, NLRP3, pro caspase-1, caspase-1 P 20, IL-18 in LX-2 FAP cells with or <t>without</t> <t>SP-13786</t> ( n = 3). (D) Immunocytochemistry of NLRP3 in LX-2 FAP cells with or without SP-13786 ( n = 3). Scale bar, 10 μm. (E) ELISA analysis of IL-18 concentration in LX-2 FAP cells ( n = 3). (F) ELISA analysis of IL-18 in the peripheral blood of Fap fl / fl or Fap ΔGfap mice with MC38-luc or Panc02-luc injection ( n = 5). (G, H) Immunofluorescence staining of NLRP3, caspase-1, or IL-18 (green) in α SMA + HSCs (gray) that adhered to the CD31 + sinusoidal blood vessels (red) in the PMN of CRC or pancreatic cancer ( n = 5). Scale bar, 10 μm. Data are presented as mean ± SEM. ∗ P < 0.05, ∗∗ P < 0.01, ∗∗∗ P < 0.001 (one-way ANOVA with Tukey's post hoc comparison in D; two-tailed unpaired t -test in E–H).
Fap α Inhibitor Sp 13786, supplied by TargetMol, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/faps/SP-13786/pmc13366303-52-7-14
Average 94 stars, based on 1 article reviews
fap α inhibitor sp 13786 - by Bioz Stars, 2026-11
94/100 stars
  Buy from Supplier

86
Huabio Inc antibodies against fap
FAP α + HSCs upregulate NF- κ B/NLRP3/caspase-1/IL-18 signaling pathway. (A) KEGG analysis of the Top100 upregulated genes in LX-2 FAP cells. (B) GO analysis of paracancerous and healthy HSCs from scRNA sequencing. (C) Western blotting analysis of FAP α , NF κ B-p65, p- NF κ B-p65, NLRP3, pro caspase-1, caspase-1 P 20, IL-18 in LX-2 FAP cells with or <t>without</t> <t>SP-13786</t> ( n = 3). (D) Immunocytochemistry of NLRP3 in LX-2 FAP cells with or without SP-13786 ( n = 3). Scale bar, 10 μm. (E) ELISA analysis of IL-18 concentration in LX-2 FAP cells ( n = 3). (F) ELISA analysis of IL-18 in the peripheral blood of Fap fl / fl or Fap ΔGfap mice with MC38-luc or Panc02-luc injection ( n = 5). (G, H) Immunofluorescence staining of NLRP3, caspase-1, or IL-18 (green) in α SMA + HSCs (gray) that adhered to the CD31 + sinusoidal blood vessels (red) in the PMN of CRC or pancreatic cancer ( n = 5). Scale bar, 10 μm. Data are presented as mean ± SEM. ∗ P < 0.05, ∗∗ P < 0.01, ∗∗∗ P < 0.001 (one-way ANOVA with Tukey's post hoc comparison in D; two-tailed unpaired t -test in E–H).
Antibodies Against Fap, supplied by Huabio Inc, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/faps/activation+anti+fap+fibroblast+protein/pm42316290-88-12-19
Average 86 stars, based on 1 article reviews
antibodies against fap - by Bioz Stars, 2026-11
86/100 stars
  Buy from Supplier

86
Procell Inc human lung adenocarcinoma a549 cells fap negative
FAP α + HSCs upregulate NF- κ B/NLRP3/caspase-1/IL-18 signaling pathway. (A) KEGG analysis of the Top100 upregulated genes in LX-2 FAP cells. (B) GO analysis of paracancerous and healthy HSCs from scRNA sequencing. (C) Western blotting analysis of FAP α , NF κ B-p65, p- NF κ B-p65, NLRP3, pro caspase-1, caspase-1 P 20, IL-18 in LX-2 FAP cells with or <t>without</t> <t>SP-13786</t> ( n = 3). (D) Immunocytochemistry of NLRP3 in LX-2 FAP cells with or without SP-13786 ( n = 3). Scale bar, 10 μm. (E) ELISA analysis of IL-18 concentration in LX-2 FAP cells ( n = 3). (F) ELISA analysis of IL-18 in the peripheral blood of Fap fl / fl or Fap ΔGfap mice with MC38-luc or Panc02-luc injection ( n = 5). (G, H) Immunofluorescence staining of NLRP3, caspase-1, or IL-18 (green) in α SMA + HSCs (gray) that adhered to the CD31 + sinusoidal blood vessels (red) in the PMN of CRC or pancreatic cancer ( n = 5). Scale bar, 10 μm. Data are presented as mean ± SEM. ∗ P < 0.05, ∗∗ P < 0.01, ∗∗∗ P < 0.001 (one-way ANOVA with Tukey's post hoc comparison in D; two-tailed unpaired t -test in E–H).
Human Lung Adenocarcinoma A549 Cells Fap Negative, supplied by Procell Inc, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/faps/a549/pm41875503-198-0-25
Average 86 stars, based on 1 article reviews
human lung adenocarcinoma a549 cells fap negative - by Bioz Stars, 2026-11
86/100 stars
  Buy from Supplier

86
Creative Biogene Inc fap
FAP α + HSCs upregulate NF- κ B/NLRP3/caspase-1/IL-18 signaling pathway. (A) KEGG analysis of the Top100 upregulated genes in LX-2 FAP cells. (B) GO analysis of paracancerous and healthy HSCs from scRNA sequencing. (C) Western blotting analysis of FAP α , NF κ B-p65, p- NF κ B-p65, NLRP3, pro caspase-1, caspase-1 P 20, IL-18 in LX-2 FAP cells with or <t>without</t> <t>SP-13786</t> ( n = 3). (D) Immunocytochemistry of NLRP3 in LX-2 FAP cells with or without SP-13786 ( n = 3). Scale bar, 10 μm. (E) ELISA analysis of IL-18 concentration in LX-2 FAP cells ( n = 3). (F) ELISA analysis of IL-18 in the peripheral blood of Fap fl / fl or Fap ΔGfap mice with MC38-luc or Panc02-luc injection ( n = 5). (G, H) Immunofluorescence staining of NLRP3, caspase-1, or IL-18 (green) in α SMA + HSCs (gray) that adhered to the CD31 + sinusoidal blood vessels (red) in the PMN of CRC or pancreatic cancer ( n = 5). Scale bar, 10 μm. Data are presented as mean ± SEM. ∗ P < 0.05, ∗∗ P < 0.01, ∗∗∗ P < 0.001 (one-way ANOVA with Tukey's post hoc comparison in D; two-tailed unpaired t -test in E–H).
Fap, supplied by Creative Biogene Inc, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/faps/fap+overexpressing/pm42119447-43-17-24
Average 86 stars, based on 1 article reviews
fap - by Bioz Stars, 2026-11
86/100 stars
  Buy from Supplier

86
Telix Pharmaceuticals quinolone based fap
FAP α + HSCs upregulate NF- κ B/NLRP3/caspase-1/IL-18 signaling pathway. (A) KEGG analysis of the Top100 upregulated genes in LX-2 FAP cells. (B) GO analysis of paracancerous and healthy HSCs from scRNA sequencing. (C) Western blotting analysis of FAP α , NF κ B-p65, p- NF κ B-p65, NLRP3, pro caspase-1, caspase-1 P 20, IL-18 in LX-2 FAP cells with or <t>without</t> <t>SP-13786</t> ( n = 3). (D) Immunocytochemistry of NLRP3 in LX-2 FAP cells with or without SP-13786 ( n = 3). Scale bar, 10 μm. (E) ELISA analysis of IL-18 concentration in LX-2 FAP cells ( n = 3). (F) ELISA analysis of IL-18 in the peripheral blood of Fap fl / fl or Fap ΔGfap mice with MC38-luc or Panc02-luc injection ( n = 5). (G, H) Immunofluorescence staining of NLRP3, caspase-1, or IL-18 (green) in α SMA + HSCs (gray) that adhered to the CD31 + sinusoidal blood vessels (red) in the PMN of CRC or pancreatic cancer ( n = 5). Scale bar, 10 μm. Data are presented as mean ± SEM. ∗ P < 0.05, ∗∗ P < 0.01, ∗∗∗ P < 0.001 (one-way ANOVA with Tukey's post hoc comparison in D; two-tailed unpaired t -test in E–H).
Quinolone Based Fap, supplied by Telix Pharmaceuticals, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/faps/based+fap+quinolone+targeting/pmc13138100-141-18-7
Average 86 stars, based on 1 article reviews
quinolone based fap - by Bioz Stars, 2026-11
86/100 stars
  Buy from Supplier

Image Search Results


( A ) Histopathology and protein content analysis was performed on tissue from mNAA, fNAA, mAAA and fAAA using immunofluorescence (IF), Western blot and ELISA. Panel A was made using BioRender.com. ( B ) IF staining of human abdominal aortic tissue for all groups with α-SMA (Green), FAP (Red) and DAPI (Blue). Co-localized cells (Yellow) represent VSMCs that express FAP marker. ( C ) IF quantification of VSMC counts using α-SMA antibody across all groups. ( D ) IF quantification of FAP+ cells using FAP antibody across all groups. ( E ) Tissue FAP concentration measured by ELISA. ( F ) Ratio of FAP+ cells that are not VSMCs. AU = Arbitrary Units. Data presented as mean ± SD. Ns>0.005, *p<0.05, **p<0.01, ***p<0.001 using Mann-Whitney-test.

Journal: bioRxiv

Article Title: Sex-based differences in fibrosis markers in human abdominal aortic aneurysms

doi: 10.64898/2026.10.23.761467

Figure Lengend Snippet: ( A ) Histopathology and protein content analysis was performed on tissue from mNAA, fNAA, mAAA and fAAA using immunofluorescence (IF), Western blot and ELISA. Panel A was made using BioRender.com. ( B ) IF staining of human abdominal aortic tissue for all groups with α-SMA (Green), FAP (Red) and DAPI (Blue). Co-localized cells (Yellow) represent VSMCs that express FAP marker. ( C ) IF quantification of VSMC counts using α-SMA antibody across all groups. ( D ) IF quantification of FAP+ cells using FAP antibody across all groups. ( E ) Tissue FAP concentration measured by ELISA. ( F ) Ratio of FAP+ cells that are not VSMCs. AU = Arbitrary Units. Data presented as mean ± SD. Ns>0.005, *p<0.05, **p<0.01, ***p<0.001 using Mann-Whitney-test.

Article Snippet: Each protein sample (25 μg) and plasma samples (diluted 1:200) from each group were analyzed using the Human FAP sandwich ELISA kit (RayBiotech, ELH-FAP-1) according to the manufacturer’s instructions.

Techniques: Histopathology, Analysis, Tissue, Immunofluorescence, Western Blot, Enzyme-linked Immunosorbent Assay, Staining, Marker, Concentration Assay, MANN-WHITNEY

miR-1290 is upregulated in breast cancer and BCAF/MB-231-derived exosomes. a Nanoparticle tracking analysis of exosomes isolated from BCAFs and MB-231 cells showing their size distribution. The mean size and standard deviation (SD) are indicated for each sample. b TEM images of exosomes isolated from BCAFs (upper) and MB-231 cells (lower) showing the characteristic morphology of the exosomes. Scale bar, 100 nm. c Western blot analysis of exosome markers (CD63, CD81, and flotillin-1), CAF markers (α-SMA and FAP) and cellular markers (GM130 and H3) in BCAF cells, MB-231 cells and their derived exosomes. d BCAF-derived exosome uptake by TNBC cells. PKH67-labeled BCAF-derived exosomes (green) were incubated with BT-549 and Hs578T cells for 1 hour. The cell nuclei were stained with Hoechst 33342 (blue). Scale bar, 20 μm. e Heatmap showing miRNA expression profiles in exosomes derived from BCAFs and MB-231 cells. Red indicates high expression, and blue indicates low expression. miR-1290 (highlighted in red) is highly expressed in both exosome types. f Volcano plots showing differentially expressed miRNAs between breast cancer or TNBC samples and normal controls in five independent GEO datasets ( GSE37963 , GSE45666 , GSE45498 , GSE38167 , and GSE61438 ). Red and blue dots represent upregulated and downregulated miRNAs, respectively, selected using fold-change and nominal p value cutoffs (|log2(fold change)| > 0.58 and nominal p < 0.05, two-tailed Welch’s t test). g Venn diagram analysis of upregulated miRNAs across the five GEO datasets revealed four commonly upregulated miRNAs. h Violin plot showing miR-1290 expression levels in serum samples from normal individuals ( N , n = 2686) and breast cancer patients ( P , n = 1280) from the GSE73002 dataset. The expression of miR-1290 was significantly upregulated in the breast cancer patient samples (*** p < 0.001, Mann‒Whitney U test). i Analysis of serum exosomal miR-1290 levels in normal ( N , n = 20) and TNBC patient ( P , n = 39) samples collected at Keimyung University Dongsan Hospital. The results support the potential of miR-1290 as a candidate diagnostic marker in an independent cohort (*** p < 0.001, Mann‒Whitney U test). j Kaplan‒Meier plot of overall survival for TNBC patients based on serum exosomal miR-1290 expression levels from Keimyung University Dongsan Hospital ( p = 0.006, log-rank test)

Journal: Signal Transduction and Targeted Therapy

Article Title: Breast cancer-associated fibroblast-derived exosomal miR-1290 promotes triple-negative breast cancer cell proliferation

doi: 10.1038/s41392-026-02922-y

Figure Lengend Snippet: miR-1290 is upregulated in breast cancer and BCAF/MB-231-derived exosomes. a Nanoparticle tracking analysis of exosomes isolated from BCAFs and MB-231 cells showing their size distribution. The mean size and standard deviation (SD) are indicated for each sample. b TEM images of exosomes isolated from BCAFs (upper) and MB-231 cells (lower) showing the characteristic morphology of the exosomes. Scale bar, 100 nm. c Western blot analysis of exosome markers (CD63, CD81, and flotillin-1), CAF markers (α-SMA and FAP) and cellular markers (GM130 and H3) in BCAF cells, MB-231 cells and their derived exosomes. d BCAF-derived exosome uptake by TNBC cells. PKH67-labeled BCAF-derived exosomes (green) were incubated with BT-549 and Hs578T cells for 1 hour. The cell nuclei were stained with Hoechst 33342 (blue). Scale bar, 20 μm. e Heatmap showing miRNA expression profiles in exosomes derived from BCAFs and MB-231 cells. Red indicates high expression, and blue indicates low expression. miR-1290 (highlighted in red) is highly expressed in both exosome types. f Volcano plots showing differentially expressed miRNAs between breast cancer or TNBC samples and normal controls in five independent GEO datasets ( GSE37963 , GSE45666 , GSE45498 , GSE38167 , and GSE61438 ). Red and blue dots represent upregulated and downregulated miRNAs, respectively, selected using fold-change and nominal p value cutoffs (|log2(fold change)| > 0.58 and nominal p < 0.05, two-tailed Welch’s t test). g Venn diagram analysis of upregulated miRNAs across the five GEO datasets revealed four commonly upregulated miRNAs. h Violin plot showing miR-1290 expression levels in serum samples from normal individuals ( N , n = 2686) and breast cancer patients ( P , n = 1280) from the GSE73002 dataset. The expression of miR-1290 was significantly upregulated in the breast cancer patient samples (*** p < 0.001, Mann‒Whitney U test). i Analysis of serum exosomal miR-1290 levels in normal ( N , n = 20) and TNBC patient ( P , n = 39) samples collected at Keimyung University Dongsan Hospital. The results support the potential of miR-1290 as a candidate diagnostic marker in an independent cohort (*** p < 0.001, Mann‒Whitney U test). j Kaplan‒Meier plot of overall survival for TNBC patients based on serum exosomal miR-1290 expression levels from Keimyung University Dongsan Hospital ( p = 0.006, log-rank test)

Article Snippet: Membranes were incubated with the following primary antibodies: CD63 (1:200; ABclonal, A5271), CD81 (1:200; ABclonal, A5270), flotillin-1 (1:1000; ABclonal, A6220), α-SMA (1:1000; ABclonal, A17910), FAP (1:1000; ABclonal, A23789 ), GM130 (1:1000; Abcam, ab52649), H3 (1:1000; Cell Signaling Technology, 4620S), ACTB (1:20,000; ABclonal, AC026), TBC1D4 (1:200; Cell Signaling Technology, 2670S), P70S6K (1:500; Cell Signaling Technology, 9202S), phospho-P70S6K (1:500; ABclonal, AP0564), and Ki67 (1:1000; Abcam, ab16667).

Techniques: Derivative Assay, Exosomes, Analysis, Isolation, Standard Deviation, Morphology, Western Blot, Labeling, Incubation, Staining, Expressing, Two Tailed Test, Blood/Plasma/Serum Samples, Diagnostic Assay, Marker

FAP α + HSCs upregulate NF- κ B/NLRP3/caspase-1/IL-18 signaling pathway. (A) KEGG analysis of the Top100 upregulated genes in LX-2 FAP cells. (B) GO analysis of paracancerous and healthy HSCs from scRNA sequencing. (C) Western blotting analysis of FAP α , NF κ B-p65, p- NF κ B-p65, NLRP3, pro caspase-1, caspase-1 P 20, IL-18 in LX-2 FAP cells with or without SP-13786 ( n = 3). (D) Immunocytochemistry of NLRP3 in LX-2 FAP cells with or without SP-13786 ( n = 3). Scale bar, 10 μm. (E) ELISA analysis of IL-18 concentration in LX-2 FAP cells ( n = 3). (F) ELISA analysis of IL-18 in the peripheral blood of Fap fl / fl or Fap ΔGfap mice with MC38-luc or Panc02-luc injection ( n = 5). (G, H) Immunofluorescence staining of NLRP3, caspase-1, or IL-18 (green) in α SMA + HSCs (gray) that adhered to the CD31 + sinusoidal blood vessels (red) in the PMN of CRC or pancreatic cancer ( n = 5). Scale bar, 10 μm. Data are presented as mean ± SEM. ∗ P < 0.05, ∗∗ P < 0.01, ∗∗∗ P < 0.001 (one-way ANOVA with Tukey's post hoc comparison in D; two-tailed unpaired t -test in E–H).

Journal: Acta Pharmaceutica Sinica. B

Article Title: Targeting FAP α -positive hepatic stellate cells ameliorates the formation of pre-metastatic niche

doi: 10.1016/j.apsb.2026.04.018

Figure Lengend Snippet: FAP α + HSCs upregulate NF- κ B/NLRP3/caspase-1/IL-18 signaling pathway. (A) KEGG analysis of the Top100 upregulated genes in LX-2 FAP cells. (B) GO analysis of paracancerous and healthy HSCs from scRNA sequencing. (C) Western blotting analysis of FAP α , NF κ B-p65, p- NF κ B-p65, NLRP3, pro caspase-1, caspase-1 P 20, IL-18 in LX-2 FAP cells with or without SP-13786 ( n = 3). (D) Immunocytochemistry of NLRP3 in LX-2 FAP cells with or without SP-13786 ( n = 3). Scale bar, 10 μm. (E) ELISA analysis of IL-18 concentration in LX-2 FAP cells ( n = 3). (F) ELISA analysis of IL-18 in the peripheral blood of Fap fl / fl or Fap ΔGfap mice with MC38-luc or Panc02-luc injection ( n = 5). (G, H) Immunofluorescence staining of NLRP3, caspase-1, or IL-18 (green) in α SMA + HSCs (gray) that adhered to the CD31 + sinusoidal blood vessels (red) in the PMN of CRC or pancreatic cancer ( n = 5). Scale bar, 10 μm. Data are presented as mean ± SEM. ∗ P < 0.05, ∗∗ P < 0.01, ∗∗∗ P < 0.001 (one-way ANOVA with Tukey's post hoc comparison in D; two-tailed unpaired t -test in E–H).

Article Snippet: LX-2 FAP cells were treated with a FAP α inhibitor SP-13786 (50 μmol/L, T7890, TargetMol, Shanghai, China) for 30 min. Gene knockdown in LX-2 Vector and LX-2 FAP cells was achieved by infection with shRNA plasmids or transfection with siRNAs, using corresponding negative controls as references.

Techniques: Analysis, Sequencing, Western Blot, Immunocytochemistry, Enzyme-linked Immunosorbent Assay, Concentration Assay, Injection, Immunofluorescence, Staining, Comparison, Two Tailed Test, Significance Assay